Response of Photofring-sensitised mesothelioma xenografts to photodynamic therapy with 514 nm light
1996

Photodynamic Therapy for Mesothelioma with 514 nm Light

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): TH Foster, SL Gibson, RF Raubertas

Primary Institution: University of Rochester School of Medicine and Dentistry

Hypothesis

Can photodynamic therapy using 514 nm light provide similar tumor control as 630 nm light in mesothelioma xenografts?

Conclusion

Photodynamic therapy with 514 nm light can achieve tumor control comparable to that of 630 nm light under certain conditions.

Supporting Evidence

  • The 20:28 irradiation protocol produced the longest delay in tumor volume doubling time.
  • All treatment regimens produced significant delays in tumor regrowth compared to controls.
  • The 514 nm treatment was statistically indistinguishable from the 630 nm treatment in terms of tumor control.

Takeaway

This study tested a new light treatment for cancer and found that it can work just as well as an older method, but with less damage to healthy tissue.

Methodology

The study involved irradiating mesothelioma xenografts in nude mice with different protocols of 514 nm light and comparing tumor regrowth delays to those from 630 nm light.

Limitations

The study was limited to specific irradiation regimens and animal models, which may not fully represent human responses.

Participant Demographics

Nude mice were used as the model organism for the study.

Statistical Information

P-Value

0.01

Confidence Interval

95% confidence intervals for median doubling times were reported.

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication